buildleaf smgt glp 1 Scam weight-loss drops marketed to Australians contain 'basically salty water', analysis finds | Scams BuildLeaf Tirzepatide GLP-1 Review: Does

[DOI] [PubMed] [Google Scholar] 49.Bjerre Knudsen L., Madsen L.W., Andersen S., Almholt K., de Boer A.S., Drucker D.J., Gotfredsen C., Egerod F.L., Hegelund A.C., Jacobsen H., et al

However, there is currently no FDA-approved indication for GLP-1 receptor agonists specifically for inflammation, and the optimal dosing strategy for anti-inflammatory effects has not been established through rigorous clinical trials

That approach can make weight loss look successful on paper while setting up problems in real life

B., Exenatide Use in the Management of Type 2 Diabetes Mellitus, Pharmaceuticals 3 (2010): 25542567

Nauck M, Stckmann F, Ebert R, Creutzfeldt W (1986) Reduced incretin effect in type 2 (non-insulin-dependent) diabetes